Under the new cross-licensing arrangement, Caliper acquires the right to sublicense AntiCancer’s fluorescent protein optical imaging patents to third-parties, alongside Caliper’s own portfolio of in vivo fluorescent and
The centers that RadNet will acquire include InSight’s centers in Simi Valley, Thousand Oaks, Westlake, Encino, Van Nuys and Valencia. The facilities operate a combination of imaging modalities,
The agreement allows for an equity-sparing, stepping up the pace of development of Cardiovascular Sciences’s anti-adhesion technology and allows Medical Technologies Enterprises’s access to and early entry into
Among these products will be the company’s Optimal Health System, which is comprised of Ambrotose – a patented blend of mixed plant saccharides; AO – a proprietary antioxidant;
Carl Silverman, vice president of licensing for Alliacense, said: “AMO is dedicated to improving the quality of vision for others through a full range of advanced refractive technologies.
The marker, developed by NST, will be manufactured and marketed by Sigma-Aldrich under the commercial name Apo-TRACE. Apo-TRACE is a member of a family of proprietary small molecules
The objective of the Phase IIa randomized, double-blind, placebo-controlled, parallel-group study is to evaluate the efficacy and safety of 200 and 500mg of PS433540 in subjects with Stage
The company had submitted the clinical trial application for P1201-07 to the Central Committee on Research Involving Human Subjects (CCMO), the regulatory authority of the Netherlands, and the
The merger agreement provides for Galderma to acquire CollaGenex in a two-step transaction. The first step will consist of a cash tender offer for all outstanding shares of
Anticipated therapeutic concentrations of ESBATech’s antibody fragments were observed in the anterior chamber (front of the eye) and in the posterior segments (back of the eye) including vitreous
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.